Cardiac Wire #34 November 7, 2022
CW Q&A: Us2.ai’s Strain Analysis Feature | The Future of In-Home Ultrasound
Cardiac Wire #33 November 3, 2022
J&J’s $16.6B Abiomed Acquisition | AFib Insights
Cardiac Wire #32 October 31, 2022
Cleerly’s Image Transfer Solution | Common Drugs Tied to AFib
Cardiac Wire #31 October 27, 2022
Persistent AFib Breakthrough | Smartphone Stethoscope App
Cardiac Wire #30 October 24, 2022
Abiomed Is on a Roll | How Do Residents View Cardiology?
Cardiac Wire #29 October 20, 2022
HeartFlow Plaque & Roadmap | Metformin for AFib
Cardiac Wire #28 October 17, 2022
Paxlovid Interacts with Heart Drugs | Healthcare Hiring Recovery
Cardiac Wire #27 October 13, 2022
Merck’s $11B Bet Pays Off | Why Pollution Causes Heart Attacks
Cardiac Wire #26 October 10, 2022
Challenging the Salt Restriction Norm | Speech Analysis App Predicts HF
Cardiac Wire #25 October 6, 2022
SGLT2i: A Universal HF Solution? | ECG-AI Boosts AFib Detection
Cardiac Wire #24 September 30, 2022
Plaque Reimbursement Milestone | Spironolactone for Alcohol Use Disorder
Cardiac Wire #23 September 28, 2022
Deprescribing Aspirin | Rocket Acquires Renovacor
Cardiac Wire #22 September 23, 2022
Aggressive LDL Reduction Strategy | Smart Stethoscopes
Cardiac Wire #21 September 21, 2022
Renal Denervation’s Comeback | TCT Announcement Surge
Cardiac Wire #20 September 15, 2022
Exercise is Medicine | Cardiac Nuclear-CT Guidelines
Cardiac Wire #19 September 14, 2022
Polypill’s Simplicity Advantage | Medtronic Adds BioButton to Portfolio
Cardiac Wire #18 September 11, 2022
GRACE 3.0: Correcting the Default Male Risk | Biosense Webster’s OCTARAY
Cardiac Wire #17 September 2, 2022
Medtronic’s Defibrillation Innovation | ESC Study Drop
Cardiac Wire #16 August 31, 2022
